Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Nasdaq & Leerink Partners

10 shared events · Importance 3 · Last updated Aug 07, 2026

Importance
3
Shared Events
10
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
57
Business
Nasdaq: Nasdaq will list BlossomHill Therapeutics' shares under the ticker 'BLSM', adding a new biotech company to its exchange. This listing is a routine but positive addition to its roster.
Leerink Partners: Leerink Partners served as a lead book-running manager, generating underwriting revenue and reinforcing its expertise in healthcare IPOs. The deal enhances its reputation in the sector.
Aug 07, 2026 · 8 articles
40
Business
Nasdaq: Nasdaq is the exchange where Scribe's shares began trading, benefiting from listing fees and increased trading activity.
Leerink Partners: Leerink Partners acted as a joint book-running manager for the IPO, earning fees and enhancing its reputation in biotech capital markets.
Jul 06, 2026 · 25 articles
35
Business
Nasdaq: Kazia's ADSs are listed on Nasdaq, and the offering may affect trading activity. The exchange benefits from listing fees and trading volume.
Leerink Partners: Leerink Partners acted as joint bookrunning manager, earning underwriting fees and strengthening its relationship with Kazia. The successful offering enhances its reputation in biotech capital markets.
Jul 20, 2026 · 22 articles
24
Business
Nasdaq: The combined company will be listed on Nasdaq under the ticker SLTE, providing a public market for the new entity.
Leerink Partners: Leerink Partners acted as financial advisor to Fulcrum Therapeutics in the merger.
Aug 17, 2026 · 6 articles
17
Business
Nasdaq: Nasdaq is the exchange on which Quoin Pharmaceuticals' ADSs are listed; the company must comply with Nasdaq rules regarding the minimum price.
Leerink Partners: Leerink Partners acted as lead placement agent for the private placement, facilitating the transaction and earning fees.
Aug 28, 2026 · 6 articles
16
Business
Nasdaq: Nasdaq is the exchange where Beta Bionics' common stock trades under the ticker BBNX, hosting the newly issued shares.
Leerink Partners: Leerink Partners served as a joint book-running manager for the offering, adding to its healthcare-focused investment banking deal flow.
Sep 15, 2026 · 7 articles
14
Business
Nasdaq: XOMA Royalty common stock delisted from Nasdaq upon completion.
Leerink Partners: Served as lead financial advisor to XOMA Royalty.
Jul 14, 2026 · 6 articles
14
Business
Nasdaq: Exchange where Lisata shares trade; LSTA closed at $1.47 before the announcement.
Leerink Partners: Served as financial advisor to Marea on the acquisition.
Sep 17, 2026 · 6 articles
12
Business
Nasdaq: SpaceX is listed on Nasdaq, and its stock performance affects the exchange's indices.
Leerink Partners: Leerink Partners has a neutral rating and a $131 price target, citing regulatory and technology uncertainties.
Jun 18, 2026 · 319 articles
7
Business
Nasdaq: Both Vertex and Crinetics are listed on Nasdaq. The acquisition may affect trading volumes and index composition, but the exchange itself is not materially impacted.
Leerink Partners: Investment bank; previously commented on Palsonify's approval.
Jul 06, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Nasdaq and Leerink Partners interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.